BRITTENHAM MARISSA (Chief Strategy Officer) sold 13.9% of their position (8.79K shares) of SURGERY PARTNERS, INC. on the open market
Open‑market sale worth $120.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001638833-26-000019
Officer· Chief Strategy Officer
Since Jan 2022
+34.45K
Net shares
Net buyer
$120.4K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
43.23K acquired · 8.79K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+17.72K
Price / share
$14.11
Trade value
$249.99K
% of position
32.4%
3/5/2026
54.62K→72.34K
Common Stock
Direct
Shares
+16.36K
Price / share
$14.11
Trade value
$230.88K
% of position
22.6%
3/5/2026
72.34K→88.70K
Common Stock
Direct
Shares
+9.15K
Price / share
$14.11
Trade value
$129.11K
% of position
10.3%
3/5/2026
88.70K→97.85K
Common Stock
Direct
Shares
−8.79K
Price / share
$13.70
Trade value
$120.35K
% of position
13.9%
3/6/2026
63.41K→54.62K
Total
Net shares
+34.45K
Net value
$489.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | A · Award | +17.72K | $14.11 | $249.99K | 32.4% | 54.62K | 72.34K |
| Common Stock Direct | 3/5/2026 | A · Award | +16.36K | $14.11 | $230.88K | 22.6% | 72.34K | 88.70K |
| Common Stock Direct | 3/5/2026 | A · Award | +9.15K | $14.11 | $129.11K | 10.3% | 88.70K | 97.85K |
| Common Stock Direct | 3/6/2026 | S · Sale | −8.79K | $13.70 | $120.35K | 13.9% | 63.41K | 54.62K |
| Total | +34.45K | $489.62K | ||||||
Derivative Transactions0
No derivative transactions reported